NVAX - Novavax Inc.

$2.85 -0.05 | -1.72%
Today's Range: 2.83 - 2.97
NVAX Avg. Daily Volume: 1,328,765
12/16/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 2.90
52 Week High 7.79
52 Week Low 0.52
Avg. Daily Vol. (Mil) 3.50
Beta (3 year) 2.59
Share Related Items
Mkt Cap (Mil) 271.12
Shares Out (Mil) 93.49
Float (Mil) 89.45
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.10
Current Ratio 6.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 844.61
Price/Book 4.05
Price/Cash Flow -8.10
Per Share Data
Earnings -0.43
Sales 0.00
Book Value 0.72
Cash Flow -0.36
Business Summary
A clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
General Information
9920 Belward Campus Drive
Rockville, MD 20850
www.novavax.com
Industry : Drugs
Sector: Health Care
Employees: 69
CEO: Dr. Rahul Singhvi
Short Interest
Current Month (Mil) 12.53
Previous Month (Mil) 13.46
Short Interest Ratio (Days) 5.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -46.80
Return on Investments -53.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Latest NVAX Headlines

Brokerage Partners

TheStreet Premium Services

All Services